NITROGEN-CONTAINING FUSED HETEROCYCLIC COMPOUND

WIPO Patent Application WO/2013/051632

A1

The present invention provides a novel compound which has excellent activity as an ERRα modulator and is useful as a therapeutic or prophylactic agent for ERRα-related diseases such as cancers, or the like. The present invention relates to a compound represented by formula (I) or a salt thereof. (In formula (I), A represents an optionally substituted cyclic group; La represents a bonding hand or the like; Lb represents a C1-3 alkylene group or the like; Lc represents a bonding hand or the like; G represents a group represented by formula Ga or Gb (wherein each of Z1, Z2, Z3 and Z4 independently represents a nitrogen atom, a carbon atom, -CH- or the like; R4 represents a hydrogen atom or the like; and R5 represents a hydrogen atom or the like); and E represents a group represented by formula Ea or Eb (wherein X represents -S- or the like; and each of R1, R2 and R3 independently represents a hydrogen atom or the like).)

TOMINARI YUSUKE (JP)
ONO KOJI (JP)
MATSUMOTO SHIGEMITSU (JP)
KATOH TAISUKE (JP)
HASUOKA ATSUSHI (JP)
IMAMURA SHINICHI (JP)

PCT/JP2012/075721

April 11, 2013

October 03, 2012

Click for automatic bibliography generation  

TAKEDA PHARMACEUTICAL (JP)

C07D401/14; A61K31/4178; A61K31/427; A61K31/437; A61K31/438; A61K31/4439; A61K31/454; A61K31/496; A61K31/506; A61K31/519; A61K31/5377; A61K31/541; A61K31/55; A61K31/551; A61P3/00; A61P3/04; A61P3/06; A61P3/10; A61P9/10; A61P9/12; A61P19/00; A61P19/02; A61P19/06; A61P25/16; A61P25/18; A61P25/22; A61P25/24; A61P25/28; A61P25/30; A61P29/00; A61P35/00; A61P35/02; A61P43/00; C07D403/06; C07D403/14; C07D405/14; C07D417/06; C07D417/14; C07D471/04; C07D471/10; C07D487/04; C07D487/10

WO2011016501A1	2011-02-10
WO2011075565A1	2011-06-23
WO2011103130A1	2011-08-25
WO2011103134A1	2011-08-25

TAKASHIMA, HAJIME (JP)
Takashima 1 (JP)

View/Download PDF      PDF Help

Previous Patent: PRINTER DEVICE

Next Patent: LIGHT EMITTING DEVICE